Equity Capital Markets

Company · CIK 1682852

Moderna, Inc.

CIK1682852 (SEC EDGAR)
Industry (SIC)2836 — Biological Products, (No Diagnostic Substances)
Incorporated inDE
Business addressMA
ListedMRNA (Nasdaq)
First annual or quarterly report2019-03-13

Offerings

4 registrations
RegistrationLabel and statusFirst filedLast eventFilings
333-271667
ShelfEffective
 2023-05-052023-05-051
333-238467
ShelfEffective
 2020-05-182020-05-202
333-236348
ShelfEffective
 2020-02-102020-02-123
333-228300
IPOFinal prospectus
 2018-11-092018-12-075

Filings

12
FiledFilingRegistrationAccession
2023-05-05S-3ASRShelf registered 333-2716670001193125-23-136568
2020-05-20424B5Shelf takedown 333-2384670001193125-20-147474
2020-05-18S-3ASRShelf registered 333-2384670001193125-20-145034
2020-02-12424B5Shelf takedown 333-2363480001193125-20-033353
2020-02-10424B5Shelf takedown 333-2363480001193125-20-029948
2020-02-10S-3ASRShelf registered 333-2363480001193125-20-029743
2018-12-07424B4Final prospectus 333-2283000001193125-18-344982
2018-12-06EFFECTDeclared effective 333-2283009999999995-18-003049
2018-12-04S-1/AAmendment 333-2283000001193125-18-341958
2018-11-28S-1/AAmendment 333-2283000001193125-18-335714
2018-11-09S-1Registration filed 333-2283000001193125-18-323562
2018-08-30DRSDraft made public 377-022420000950123-18-009220

All filings of this company · CSV